Federal contract award
75N93019C00061
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $11.2M |
| Current contract value | $11.2M |
| Potential contract value / ceiling | $19.1M |
| Start date | Sep 9, 2019 |
| Current end date | Feb 18, 2026 |
| Potential end date | May 31, 2027 |
| Latest award activity | Aug 7, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 31 of 31 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 7, 2026 | P00030 | $-123 | THE PURPOSE OF THIS MODIFICATION IS TO TERMINATE THE CONTRACT FOR CONVENIENCE EFFECTIVE FEBRUARY 18, 2026 |
| Aug 5, 2026 | P00029 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO TERMINATE THE CONTRACT FOR CONVENIENCE EFFECTIVE FEBRUARY 18, 2026 |
| Sep 3, 2025 | P00028 | $-11 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE 5TH YEAR FUNDS FROM LINE 6 |
| Jun 4, 2025 | P00027 | $0 | EXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR. |
| May 8, 2025 | P00026 | $0 | EXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR. |
| May 2, 2025 | P00025 | $0 | EXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR. |
| Nov 12, 2024 | P00024 | $416.3K | EXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR. |
| Jul 24, 2024 | P00023 | $0 | EXTEND PERFORMANCE TIME OF OPTIONS DUE TO DELAYS IN CHANGING FROM ONE MANUFACTURING CONTRACTOR TO ANOTHER MANUFACTURING CONTRACTOR. |
| Apr 29, 2024 | P00022 | $1.3M | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Sep 29, 2023 | P00021 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Apr 11, 2023 | P00020 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Nov 18, 2022 | P00019 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jul 28, 2022 | P00018 | $1.3M | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jun 30, 2022 | P00017 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Mar 15, 2022 | P00016 | $29.3K | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Feb 8, 2022 | P00015 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Dec 22, 2021 | P00014 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Nov 30, 2021 | P00013 | $0 | EO14042 - TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Sep 7, 2021 | P00012 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jul 29, 2021 | P00011 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jun 25, 2021 | P00010 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| May 6, 2021 | P00009 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Apr 26, 2021 | P00008 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Mar 2, 2021 | P00007 | $421.7K | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Feb 9, 2021 | P00006 | $2.1M | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jan 19, 2021 | P00005 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Nov 27, 2020 | P00004 | $0 | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| May 15, 2020 | P00003 | $2.3M | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Jan 31, 2020 | P00002 | $521.3K | TO DEVELOP A PLUG-AND-PLAY TECHNOLOGY PLATFORM TO EXPEDITE THE PRODUCTION OF VACCINE CANDIDATES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES. |
| Sep 9, 2019 | P00001 | $180.4K | TO EXERCISE OPTION 1 AND TO ISSUE A NCE. |
| Aug 30, 2019 | 0 | $2.8M | TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-05-31 (211 days from calculation)
- +35 points
- 103 historical awards in this buyer and category group
- +15 points
- 31 recorded award transactions
- +10 points
- Latest award action: 2026-08-07
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.